These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 15049839)
1. Synthesis and activity of the melanocortin Xaa-d-Phe-Arg-Trp-NH tetrapeptides with amide bond modifications. Todorovic A; Holder JR; Scott JW; Haskell-Luevano C J Pept Res; 2004 Mar; 63(3):270-8. PubMed ID: 15049839 [TBL] [Abstract][Full Text] [Related]
2. N-terminal fatty acylated His-dPhe-Arg-Trp-NH(2) tetrapeptides: influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytes. Todorovic A; Holder JR; Bauzo RM; Scott JW; Kavanagh R; Abdel-Malek Z; Haskell-Luevano C J Med Chem; 2005 May; 48(9):3328-36. PubMed ID: 15857138 [TBL] [Abstract][Full Text] [Related]
3. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands. Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template. Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position. Holder JR; Xiang Z; Bauzo RM; Haskell-Luevano C J Med Chem; 2002 Dec; 45(26):5736-44. PubMed ID: 12477357 [TBL] [Abstract][Full Text] [Related]
7. Modified melanocortin tetrapeptide Ac-His-dPhe-Arg-Trp-NH at the arginine side chain with ureas and thioureas. Joseph CG; Sorensen NB; Wood MS; Xiang Z; Moore MC; Haskell-Luevano C J Pept Res; 2005 Nov; 66(5):297-307. PubMed ID: 16218996 [TBL] [Abstract][Full Text] [Related]
9. Characterization of aliphatic, cyclic, and aromatic N-terminally "capped" His-D-Phe-Arg-Trp-NH2 tetrapeptides at the melanocortin receptors. Holder JR; Marques FF; Xiang Z; Bauzo RM; Haskell-Luevano C Eur J Pharmacol; 2003 Feb; 462(1-3):41-52. PubMed ID: 12591094 [TBL] [Abstract][Full Text] [Related]
10. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach. Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues. Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947 [TBL] [Abstract][Full Text] [Related]
12. Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity. Joseph CG; Wilczynski A; Holder JR; Xiang Z; Bauzo RM; Scott JW; Haskell-Luevano C Peptides; 2003 Dec; 24(12):1899-908. PubMed ID: 15127941 [TBL] [Abstract][Full Text] [Related]
13. Functional characterization of the modified melanocortin peptides responsible for ligand selectivity at the human melanocortin receptors. Chen M; Georgeson KE; Harmon CM; Haskell-Luevano C; Yang Y Peptides; 2006 Nov; 27(11):2836-45. PubMed ID: 16730390 [TBL] [Abstract][Full Text] [Related]
14. Analogs of sub-nanomolar hMC1R agonist LK-184 [Ph(CH2)3CO-His-D-Phe-Arg-Trp-NH2]. An additional binding site within the human melanocortin receptor 1? Koikov LN; Ebetino FH; Solinsky MG; Cross-Doersen D; Knittel JJ Bioorg Med Chem Lett; 2004 Aug; 14(15):3997-4000. PubMed ID: 15225714 [TBL] [Abstract][Full Text] [Related]
15. End-capping of the modified melanocortin tetrapeptide (p-Cl)Phe-D-Phe-Arg-Trp-NH2 as a route to hMC4R agonists. Koikov LN; Ebetino FH; Hayes JC; Cross-Doersen D; Knittel JJ Bioorg Med Chem Lett; 2004 Oct; 14(19):4839-42. PubMed ID: 15341935 [TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors: part 2 modifications at the Phe position. Holder JR; Bauzo RM; Xiang Z; Haskell-Luevano C J Med Chem; 2002 Jul; 45(14):3073-81. PubMed ID: 12086493 [TBL] [Abstract][Full Text] [Related]
18. Peptide and small molecules rescue the functional activity and agonist potency of dysfunctional human melanocortin-4 receptor polymorphisms. Xiang Z; Pogozheva ID; Sorenson NB; Wilczynski AM; Holder JR; Litherland SA; Millard WJ; Mosberg HI; Haskell-Luevano C Biochemistry; 2007 Jul; 46(28):8273-87. PubMed ID: 17590021 [TBL] [Abstract][Full Text] [Related]
19. Potent and selective agonists of alpha-melanotropin (alphaMSH) action at human melanocortin receptor 5; linear analogs of alpha-melanotropin. Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A Peptides; 2007 May; 28(5):1020-8. PubMed ID: 17376561 [TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors. 1. Modifications at the His position. Holder JR; Bauzo RM; Xiang Z; Haskell-Luevano C J Med Chem; 2002 Jun; 45(13):2801-10. PubMed ID: 12061882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]